The Keto Diet and Cancer: Is Metabolism not Genetics The Key? | In Vivo w/ Dr. Tomas Duraj | Ep. 23

In this episode of In Vivo, we sit down with Dr. Tomás Duraj to challenge a century of conventional wisdom about cancer. For decades, the dominant theory has been the somatic mutation theory, which suggests cancer is a genetic disease caused by random mutations.Dr. Duraj and his colleagues are proposing a paradigm shift, viewing cancer as a mitochondrial metabolic disease. This theory explains that cancer cells are fundamentally different from healthy cells in how they produce energy, relying on a less efficient form of energy production through glucose and glutamine fermentation. This metabolic inflexibility is what makes them vulnerable.We discuss the history of cancer research, the flaws in the current paradigm, and the exciting potential of a new approach: Ketogenic Metabolic Therapy (KMT). Dr. Duraj explains how KMT, which includes a ketogenic diet, is not just a diet but a comprehensive strategy to create a metabolic disadvantage for cancer cells while protecting and empowering healthy ones.We cover:The Warburg Effect and the metabolic theory of cancerThe difference between how healthy cells and cancer cells generate ATPHow a ketogenic diet and other therapies can synergistically target cancer's vulnerabilitiesThe potential of KMT in treating aggressive cancers like glioblastomaThis is a must-watch for anyone interested in a new perspective on cancer research and treatment.Connect with Dr. Tomás Duraj: http://www.tomasduraj.com/Dr. Duraj's 2024 paper on KMT: https://pubmed.ncbi.nlm.nih.gov/39639257/In Vivo on X - https://x.com/InVivoPodOnXIn Vivo on Youtube - https://www.youtube.com/@InVivoPodcastIn Vivo on Apple Podcast - https://podcasts.apple.com/us/podcast/in-vivo/id1775578563In Vivo on Amazon Podcasts - https://music.amazon.ca/podcasts/1ac4dbec-df46-4d1f-b0a1-742e9656ef44/in-vivo